Who
Joerg Kuechen
Head of Corporate M&A
Company insider
Files Form 4 as: Head of Corporate M&A, Cognex.
In numbers
- Trades disclosed
- 74
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $7.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Aug 2022
- Last trade
- 21 Feb 2026
- Last filed
- 24 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —6,355 at $0.00 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code F | $172K3,073 at $56.03 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,355 at $0.00 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,355 at $0.00 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —6,355 at $0.00 | filing |
| 21 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code F | $172K3,073 at $56.03 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | $364K11,029 at $33.04 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —11,029 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —35,642 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,325 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $617K11,029 at $55.98 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | $480K12,500 at $38.39 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —11,029 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —35,642 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,325 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $700K12,500 at $56.03 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | $1.4M35,642 at $39.44 | filing |
| 20 Feb 2026filed 24 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $2.0M35,642 at $56.03 | filing |
News
Barclays Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) StockCGNX · themarketsdaily.com · 12 Oct 2026Cognex (NASDAQ:CGNX) Stock Price Down 7.3% After Analyst DowngradeCGNX · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Joerg Kuechen; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.